Clinical Trial Update: Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating nimotuzumab with concurrent chemoradiotherapy for locally advanced cervical cancer is being reported; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Cancer
• Cervical Squamous Cell Carcinoma in Situ

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Neoplasms, Cervical Adenosquamous Cell Carcinoma | Phase 2 | Status: UNKNOWN